iTalkBetter app significantly improves speech in stroke patients

A UCL-developed app that provides speech therapy for people with the language disorder aphasia has been found to significantly improve their ability to talk.

iTalkBetter, developed by the Neurotherapeutics Group at the UCL Queen Square Institute of Neurology, provides users the digital platform to practice over 200 commonly used words, in their own time and without any limits on the amount of therapy they receive.

While employing games to maintain engagement, the app’s integrated speech recogniser analyses speech in real time to give the user feedback on whether they have named the displayed item correctly.

A new study, published in eClinicalMedicine, found that when used over a six-week period for around 90 minutes per day, iTalkBetter significantly improved patients’ ability to name items by 13% for the 200 commonly used words. Importantly, spontaneous speech was also found to improve.

Aphasia occurs when a person suffers brain damage, usually to the organ’s left side, leading to difficulties with speech or language. The most common causes are stroke, severe head injury and brain tumours.

Symptoms can vary widely from person to person. However, most people with aphasia have some trouble with their speaking, and may also experience issues with writing, reading and listening.

Currently, the NHS provides around 12 hours of speech and language therapy with further face-to-face therapy available via some charities or privately.

Corresponding author, Professor Alex Leff (UCL Institute of Cognitive Neuroscience and UCL Queen Square Institute of Neurology), said: “Most health care systems massively under dose people with aphasia in terms of the hours of speech language therapy that they are provided with. App delivered therapy is one solution to this problem.

“This is the first randomised controlled trial of an app designed to improve speaking that transfers to a naturalistic speaking task and show an effect on connected speech.”

The researchers tested the app in a phase II randomised clinical trial on 27 people with aphasia as a result of a stroke, between September 2020 and March 2022.

Researchers also used structural and functional magnetic resonance imaging (MRI) to see what happened in the brains of participants when using the app.

Structurally, they found that brain regions related to language perception, production and control increased in volume after practice with iTalkBetter.

Professor Leff added: “This is the first task-based fMRI study in people with aphasia to identify dose-related changes in brain function. The more people with aphasia practiced, the more they were able to activate key auditory processing areas in the undamaged hemisphere.”

iTalkBetter will soon be rolled out as an app available to all suitable patients to use.

Reference:

Catherine Doogan, Victoria Fleming, Pedro Quijada Leyton, David Barbera, Peter Zeidman, Efficacy of a gamified digital therapy for speech production in people with chronic aphasia (iTalkBetter): behavioural and imaging outcomes of a phase II item-randomised clinical trial, EClinicalMedicine, https://doi.org/10.1016/j.eclinm.2024.102483.

Powered by WPeMatico

Add on Exebacase to antibiotics Falls Short in Treating MRSA Bacteremia, reveals study

Staphylococcus aureus bacteremia, especially when caused by methicillin-resistant S. aureus (MRSA), poses a significant challenge in healthcare. Seeking innovative solutions, the DISRUPT study investigated the efficacy of exebacase, a first-in-class antistaphylococcal lysin, as an adjunct to standard-of-care antibiotics. However, the study faced unexpected challenges, prompting a closer look at the results and their implications.

The study was published in the journal of Clinical Infectious Diseases by Vance G. Fowler and colleagues. In this phase 3 superiority-design study, 259 patients with S. aureus bacteremia/endocarditis were randomized to receive either a single dose of IV exebacase or a placebo alongside standard-of-care antibiotics. The primary endpoint was the clinical response at Day 14 in the MRSA population.

  • Surprisingly, the study was stopped for futility by the Data Safety Monitoring Board, as exebacase failed to enhance the clinical response at Day 14 in patients with MRSA bacteremia/endocarditis.

  • Clinical response rates at Day 14 in the MRSA population were 50.0% for exebacase + antibiotics vs. 60.6% for antibiotics alone, with no statistically significant difference (P = 0.392).

  • Notably, adverse events were similar across groups, and no hypersensitivity events related to exebacase were reported.

The DISRUPT study’s unexpected outcome challenges the promising phase 2 data that demonstrated the potential of exebacase + antibiotics in MRSA bacteremia/endocarditis. The higher-than-expected clinical response rate in the antibiotics alone group further complicates the interpretation. Heterogeneity within the study population and the relatively small sample size might have contributed to imbalances in Day 14 clinical outcomes. These results emphasize the complexity of studying S. aureus bacteremia/endocarditis and provide crucial lessons for future research in this field.

The DISRUPT study highlights the need for caution in interpreting phase 2 data, emphasizing the importance of large, well-designed phase 3 trials. Future studies in S. aureus bacteremia/endocarditis should carefully consider population heterogeneity and adequately power the study to minimize the risk of imbalances in outcomes.

Reference:

Fowler, V. G., Das, A. F., Lipka-Diamond, J., Ambler, J. E., Schuch, R., Pomerantz, R., Cassino, C., Jáuregui-Peredo, L., Moran, G. J., Rupp, M. E., Lachiewicz, A. M., Kuti, J. L., Wise, R. A., Kaye, K. S., Zervos, M. J., & Nichols, W. G. Exebacase in addition to standard-of-care antibiotics for staphylococcus aureus bloodstream infections and right-sided infective endocarditis: A phase 3, superiority-design, placebo-controlled, randomized clinical trial (DISRUPT). Clinical Infectious Diseases,2024;ciae043. https://doi.org/10.1093/cid/ciae043

Powered by WPeMatico

Regional anesthesia not linked to recurrence of colorectal cancer after surgery, suggests study

General or regional anesthesia’s effect on colorectal cancer recurrence after surgery

The research study evaluated the recurrence of colorectal cancer (CRC) under general anaesthesia (GA) or regional anaesthesia (RA) in patients undergoing CRC surgery, along with the impact of anaesthetic agents on the immune system, neuroendocrine response, and the metastatic process. The study also discussed the implications of primary tumour location and tumour stage on the recurrence rate and the overall survival of patients with early-stage CRC.

Systematic Review Methodology

The authors performed a systematic review following PRISMA and SWiM guidelines, including studies that evaluated the effects of GA or RA on CRC recurrence. They conducted an electronic literature search and selected six studies for the review, with a total of 58,075 patients undergoing CRC surgery. The included studies utilized various anaesthetic agents and techniques, such as total intravenous anaesthesia (TIVA), inhalational anaesthesia, epidural anaesthesia, and spinal anaesthesia. The risk of bias and quality assessment for the included studies were evaluated using the Newcastle-Ottawa Scale (NOS).

Primary and Secondary Outcomes

The primary outcome of interest was cancer recurrence after surgery, while secondary outcomes included disease-free survival (DFS), overall survival, and mortality. The review revealed no significant association between anaesthesia type and CRC recurrence. Additionally, no conclusive improvement was found in DFS. The evidence quality was deemed very low for cancer recurrence and low for DFS, thus leaving scope for further studies with larger sample sizes and longer follow-up periods to determine the association between CRC recurrence and anaesthesia.

Factors Contributing to Recurrence

The authors discussed the potential factors contributing to recurrence or metastasis after cancer surgery, including minimal residual disease, surgical stress, and the use of anaesthetic agents and techniques, which may affect the immune and inflammatory responses. Furthermore, they highlighted the conflicting findings on the impact of different anaesthetic agents on cancer recurrence in various types of cancer and the need for further prospective clinical trials to elucidate the role of anaesthetic agents on cancer recurrence and prognosis.

Concluding Remarks on CRC Recurrence

In conclusion, the review found no significant association between regional anaesthesia and CRC recurrence. However, the authors emphasized the limitations of the existing studies, including various confounding factors, and highlighted the need for further well-designed randomized controlled trials to establish the relationship between CRC recurrence and anaesthesia.

The study identified limitations in the existing literature and suggested the need for larger prospective clinical trials to address these limitations and provide clearer insights into the impact of anaesthesia on CRC recurrence.

Reference –

Chachra, Alisha; Gunashekar, Satheesh; Kumar, Ajit; Thakur, Nitish; Jagath, Arun. Impact of general or regional anaesthesia on recurrence of colorectal cancer after surgery: Systematic review. Indian Journal of Anaesthesia 67(12):p 1061-1070, December 2023. | DOI: 10.4103/ija.ija_478_23

Powered by WPeMatico

Increase in annual cardiorespiratory fitness by more than 3% linked to 35% lower prostate cancer risk: Study

An increase in annual cardiorespiratory fitness by 3% or more is linked to a 35% lower risk of developing, although not dying from, prostate cancer, suggests research published online in the British Journal of Sports Medicine.

The findings prompt the researchers to conclude that men should be encouraged to improve their level of fitness to help lower their chances of getting the disease.

There are relatively few known risk factors for prostate cancer, note the researchers. And while there’s good evidence for the beneficial effects of physical activity on the risk of several cancers, the associations with prostate cancer are less clear-cut.

Most previously published studies have assessed fitness at only one time point, and none has looked at the potential impact of fitness on both the risk of developing and dying from prostate cancer, explain the researchers.

They therefore wanted to find out if improvements in cardiorespiratory fitness over time might influence these risks, drawing on a national occupational health profile assessment database.

The database collected information on physical activity, lifestyle, perceived health, measurement of body mass and height, and the results of at least 2 cardiorespiratory fitness tests, measured by peddling on a stationary cycle, for 57,652 men out of a total of 181,673.

Annual cardiorespiratory fitness measurements were expressed as absolute and relative V02 max-the amount (volume) of oxygen the body uses while exercising as hard as possible-and divided into groups according to whether these increased annually by more than 3%, fell by more than 3%, or remained stable.

And to assess whether change in fitness on prostate cancer risk varied by baseline fitness, 3 equally sized groups of low, moderate, and high cardiorespiratory fitness were created.

For the incidence analysis, all participants were monitored from the date of the last assessment to the date of their prostate cancer diagnosis, or death from any cause, or until 31 December 2019, whichever came first.

For the mortality analysis, their survival was tracked from the date of their second assessment to either the date of death from prostate cancer, death from any cause, or until 31 December 2019, whichever came first.

During an average period of nearly 7 years, 592 men (1% of the total sample) were diagnosed with prostate cancer, and 46 (0.08%) died of their disease.

An annual percentage increase in absolute cardiorespiratory fitness was associated with a 2% lower risk of prostate cancer, but not death, after accounting for potentially influential factors, including age, education level, year of test, weight (BMI), and smoking status.

When participants were grouped according to whether their cardiorespiratory fitness had increased, remained stable, or had fallen, those whose fitness had improved by 3% or more a year were 35% less likely to develop prostate cancer than those whose fitness had declined, after accounting for potentially influential factors.

When the participants were grouped by their cardiorespiratory fitness at their first assessment, the association between fitness and a reduction in prostate cancer risk was only statistically significant (15% lower) for those with a moderate level of fitness to begin with.

This is an observational study, and as such, can’t establish causal factors, added to which genetic factors have a major role in both a person’s cardiorespiratory fitness and cancer risk, highlight the researchers.

But they nevertheless conclude: “The results highlight the importance of [cardiorespiratory fitness] for prostate cancer risk, which has been challenging to determine with single time point studies” adding: “Improvements in [cardiorespiratory fitness] in adult men should be encouraged and may reduce the risk of prostate cancer.”

Reference:

Bolam KA, Bojsen-Møller E, Wallin P, et alAssociation between change in cardiorespiratory fitness and prostate cancer incidence and mortality in 57 652 Swedish menBritish Journal of Sports Medicine Published Online First: 30 January 2024. doi: 10.1136/bjsports-2023-107007.

Powered by WPeMatico

NEET 2024 Exam Scam in Vadodara: School Principal among 2 More Arrested

Vadodara- The Panchmahal police have recently arrested two more accused in the ongoing investigation into the National Eligibility cum Entrance Test (NEET) 2024 exam scam at a School in Godhra. The said School was one of the NEET 2024 exam centres in Vadodara.

According to a recent report by Indian Express, the police have arrested the Jai Jalaram School principal Sharma, who was also the NEET coordinator for the Godhra centre, and a Godhra resident Vohra. 

Tthe Indian Express has reported that Sharma has been arrested for allegedly being in connivance with prime accused  Bhatt. Consequently, Vohra, who had been arrested for allegedly paying Rs 7 lakh to Bhatt, which was recovered from his vehicle during a raid by the education department on May 5 to thwart the alleged plan to tamper with the NEET answer sheets.

After the matter came to light, on the complaint of Panchmahal district education officer Kirit Kumar Patel, an FIR was lodged at the Godhra taluka police station on May 8 against Tushar Bhatt, Parshuram Roy and Aarif Vohra for allegedly playing a criminal conspiracy to help at least 26 students pass the NEET exam “with meritorious ranks through unfair means”.

The FIR stated that the attempted malpractice was “foiled” on May 5 during a raid at the NEET centre by an inspection squad of the education department. The raid was conducted following input received by the Panchmahal collector. Typically, the Panchmahal collector had a tip-off that Bhatt was planning to commit irregularities during the NEET 2024 exam and help some students.

According to the FIR, it had been decided that the students would appear for the exam and allegedly “only attempt the questions, which they could solve” while leaving the “rest of the answer book blank to be filled up by the agents after the exam when the answer book is submitted to the exam supervisor”, reports Indian Express.

Speaking to the Indian Express, investigating Officer, Godhra Deputy Superintendent of Police N V Patel, said “Sharma and Bhatt were in connivance to tamper with the OMR answer sheets that were to be left blank by the students involved in this scam… The investigation has revealed that Sharma was in the know and supportive of Bhatt’s plan to tamper with the OMR sheets. His name had cropped up during the interrogation of the accused, especially Bhatt”.

So far, five people have been arrested in this case they are Anand, Roy, Bhatt,  Sharma and Vohra.

Talking about Anand, he is based in Maneja, Vadodara but hails from Bihar. He is an education consultant, who put students in touch with Parshuram Roy of Roy Overseas (Vadodara-based immigration agency)… Students from the other states had also contacted Anand through his ads on social media and he had referred some students to Roy. We have recovered a list of students from Anand. He used to bring medical aspirants and connect them with a person named Parshuram Roy, who runs a visa and overseas education consultancy firm in Vadodara. Bhatt, a Geography teacher at Jai Jalaram School and the superintending officer of the NEET exam. However, he was arrested on Saturday, a day before the arrest of Purushottam Sharma.

However, “Anand has been sent to police custody till May 23 by a local court while Sharma will soon be produced in court”, informed N V Patel. Meanwhile, the local court has extended the police custody of Parshuram Roy, from whose office the police have recovered cheques signed by NEET aspirants involved in the fraud.

Also, Patel informed that an investigation is also being conducted to ascertain the identity of the students who had approached the accused to commit malpractices to pass NEET with good rank in merit.

Powered by WPeMatico

Laurus Lab Gets CDSCO Panel Nod To Manufacture and Market Sodium Phenylbutyrate Powder

New Delhi: Noting that urea cycle disorder is a very rare disease and there are unmet medical needs in the country, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has given its nod to Laurus Lab to manufacture and market Sodium Phenylbutyrate powder.

However, this approval is subject to the condition that the firm should conduct a Phase IV clinical trial for which Phase IV clinical trial protocol is to be submitted to CDSCO within 3 months.

This came after Laurus Labs presented its bioequivalence (BE) study report for a grant of permission to manufacture and market Sodium Phenylbutyrate powder.
The committee noted that Urea Cycle Disorder is a very rare disease and there is unmet medical need in the country. The committee also noted that the drug is already approved in the US, Europe, and Canada.

Sodium phenylbutyrate is used together with a proper diet to help treat urea cycle disorders, including carbamyl phosphate synthetase deficiency (CPS), ornithine transcarbamylase deficiency (OTC), or argininosuccinate synthetase (AS).

Sodium phenylbutyrate metabolites allow the kidneys to excrete excess nitrogen in place of urea and coupled with dialysis, amino acid supplements, and a protein-restricted diet, children born with urea cycle disorders can usually survive beyond 12 months. Patients may need treatment for all their life.

At the recent SEC meeting for the endocrinology and metabolism held on 16th May 2024, the expert panel reviewed the BE study report of Sodium Phenylbutyrate powder presented by Laurus Labs.
After detailed deliberation, the committee recommended the grant of permission to manufacture and market the applied drug for proposed indication subject to the condition that the firm shall conduct a Phase IV clinical trial for which Phase IV CT protocol is to be submitted to CDSCO within 3 months of approval for further evaluation by the committee.

Also Read:CDSCO Panel grants Novartis Protocol Amendment Proposal to study Remibrutinib in Chronic Spontaneous Urticaria

Powered by WPeMatico

ICMR issues new Dietary Guidelines for inactive women

The Indian Council of Medical Research (ICMR) released a comprehensive dietary guideline for people residing in India. These guidelines, comprising 17 key points, underscored the importance of addressing unhealthy dietary habits and highlight the health risks associated with mislabeling food products.
Notably, the report highlighted the dietary needs of women who lead sedentary lifestyles, including working women and mothers balancing multiple roles daily.

Powered by WPeMatico

2 AIIMS Rishikesh doctors among 5 held for MD exam cheating scandal

Amid the reports of the NEET UG paper leak scam, Police have now discovered a cheating scam in the Institute of National Importance Combined Entrance Test for Doctor of Medicine (MD) exam, held by the All India Institute of Medical Sciences (AIIMS).
In this connection, Uttarakhand Police arrested two AIIMS-Rishikesh doctors and three other individuals on Sunday evening for allegedly facilitating cheating from a car near Barrage Road in Rishikesh, reports TOI.
For more information click on the link below:

Powered by WPeMatico

Ayushman Bharat Fraud: Rajkot Paediatrician expelled for manipulating reports, extracting Rs 2.53 crore

Rajkot: Taking action against a paediatrician for allegedly manipulating the reports of newborns to extract a huge sum of money from the Government’s Ayushman Bharat Scheme, the State health department recently expelled him from the Ayushman Card scheme of health insurance.  

This comes after the insurance company and the health department found that the doctor had been involved in unethical behaviour. This included tampering with medical records to portray patients’ conditions negatively, thus exaggerating the severity of their health issues.  

The doctor running Nihit Babycare Hospital at Rajkot in Gujarat was accused of having admitted perfectly healthy children to the Intensive Care Unit (ICU) to fraudulently obtain funds from the Ayushman scheme.

Also read- MP Doctor Angrily Snaps At Home Guard, Video Goes Viral

As per the Desh Gujarat news report, the doctor will first verify if the patient’s family is covered by the Ayushman card scheme. Once it is confirmed that the family is a beneficiary of the scheme, he will gather samples from the child and send them to the Mangalam laboratory.

Subsequently, the reports will be reviewed and the child will be admitted to the NICU for 7-10 days. The information would be uploaded to the government portal of the Ayushman scheme, and a claim of Rs. 9,000 to Rs. 10,000 per day would be made under the scheme.

So far, a total of 1483 children have been admitted to his hospital under the scheme which was linked with his hospital two years ago. However, the doctor had shown a record of 523 admissions, for which he has claimed Rs. 2.53 crore.

It is estimated that he obtained the amount in a short period of only 8 months by providing unnecessary medical treatment to the infants using this method, according to VOI

His attempt to continuously deceive the government failed when Mr Imran Houthi of Divya Bhaskar brought the incident to light. This ex-employee revealed how the accused doctor admitted children into the hospital by intentionally creating falsified negative reports.

Also read- CAT Refuses To Grant Relief To Doctor Removed From HOD Post

Powered by WPeMatico

NMC adopts uniform fee for individuals, medical colleges filling appeals

The National Medical Commission (NMC) has decided to adopt a uniform fee structure for medical colleges and individuals filing 1st and 2nd appeals before the Commission. Further, the NMC has warned the concerned that in case of deficiencies, the appeals are liable to be rejected on technical grounds.
In its 13th meeting, the Apex Medical Regulator in the country decided on a uniform fee of Rs 50,000 in cases of appeals filed by colleges or institutes related to the academic year 2024-2025 onwards. The Commission decided that Rs 5,000 shall be charged in all the cases of appeals filed by individuals.
For more information, click on the link below:

Powered by WPeMatico